Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors
Status:
Terminated
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Methylphenidate may decrease side effects of radiation therapy. It is not yet
known if methylphenidate is effective in improving quality of life in patients with primary
or metastatic brain tumors.
PURPOSE: Randomized phase III trial to determine the effectiveness of methylphenidate in
improving quality of life in patients who have brain tumors and are undergoing radiation
therapy.
Phase:
Phase 3
Details
Lead Sponsor:
Wake Forest Baptist Health Wake Forest University Health Sciences